Related MeSH Hierarchy (5)
Diseases [C] » Endocrine System Diseases [C19] » Thyroid Diseases » Thyroid Neoplasms » Thyroid Cancer, Papillary
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Adenocarcinoma, Papillary » Thyroid Cancer, Papillary
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Thyroid Neoplasms » Thyroid Cancer, Papillary
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Thyroid Neoplasms » Thyroid Cancer, Papillary
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Thyroid Neoplasms » Thyroid Cancer, Papillary
Description
An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer. MeSH
Hierarchy View
Phase 4 Indicated Drugs (2)
Phase 2 Indicated Drugs (13)
Phase 1 Indicated Drugs (7)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 2 Indications (23)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
